Evidence map›Paper›PMID 27611441›Full record

ArticlePloS one2016

Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China.

Jian-Xing Wang, Shuang-Li Zhu, Jing Wang, Yi Lin, Yao-Wen Pei, Da-Peng Sun, Yong Zhang, Xian-Jun Wang, Wen-Bo Xu, Shu-Jun Ding

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jian-Xing WangInstitute for Viral Disease Control and Prevention, Shandong Provincial Key Laboratory of Communicable Disease Controland Prevention, Shandong Center for Disease Control and Prevention, Jinan Shandong 250014, China.ORCID http://orcid.org/0000-0001-5098-1001
Shuang-Li ZhuWHO WPRO Regional Polio Reference Laboratory and Key Laboratory of Medical Virology and Viral Diseases, National Health and Family Planning Commission of China, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Jing WangInstitute for Viral Disease Control and Prevention, Shandong Provincial Key Laboratory of Communicable Disease Controland Prevention, Shandong Center for Disease Control and Prevention, Jinan Shandong 250014, China.
Yi LinInstitute for Viral Disease Control and Prevention, Shandong Provincial Key Laboratory of Communicable Disease Controland Prevention, Shandong Center for Disease Control and Prevention, Jinan Shandong 250014, China.
Yao-Wen PeiInstitute for Viral Disease Control and Prevention, Shandong Provincial Key Laboratory of Communicable Disease Controland Prevention, Shandong Center for Disease Control and Prevention, Jinan Shandong 250014, China.
Da-Peng SunInstitute for Viral Disease Control and Prevention, Shandong Provincial Key Laboratory of Communicable Disease Controland Prevention, Shandong Center for Disease Control and Prevention, Jinan Shandong 250014, China.
Yong ZhangWHO WPRO Regional Polio Reference Laboratory and Key Laboratory of Medical Virology and Viral Diseases, National Health and Family Planning Commission of China, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Xian-Jun WangInstitute for Viral Disease Control and Prevention, Shandong Provincial Key Laboratory of Communicable Disease Controland Prevention, Shandong Center for Disease Control and Prevention, Jinan Shandong 250014, China.
Wen-Bo XuWHO WPRO Regional Polio Reference Laboratory and Key Laboratory of Medical Virology and Viral Diseases, National Health and Family Planning Commission of China, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Shu-Jun DingInstitute for Viral Disease Control and Prevention, Shandong Provincial Key Laboratory of Communicable Disease Controland Prevention, Shandong Center for Disease Control and Prevention, Jinan Shandong 250014, China.
Shandong Center for Disease Control and Prevention · CNNational Health and Family Planning Commission · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHand, foot, and mouth disease has become very common in mainland of China in recent years, and enterovirus A71 and coxsackievirus A16 are its major etiologic factors. Here we investigated the seroprevalence of enterovirus A71 and coxsackievirus A16 based on a large group of healthy individuals in Shandong province, China.

methodsA total of 1378 healthy individuals were tested for serum neutralizing antibodies against enterovirus A71 and coxsackievirus A16 using a micro neutralization test.

resultsThe overall seroprevalence of enterovirus A71 neutralizing antibodies was 74.75%. It increased significantly from 48.84% in children aged 0-1 years old to 88.64% in those aged 20-29 years (p < 0.01) and decreased to 85.71% in adults > 40 years old with a significant gender-specific difference (p < 0.01). The overall coxsackievirus A16 antibody prevalence was 71.77%. It increased significantly from 39.53% in children aged 0-1 years to 80.68% in those aged 10-19 years (p < 0.01) and decreased to 75.63% in adults >40 years without a gender-specific difference. Nearly 50% of the children <1 year were susceptible to enterovirus A71 infection versus 40% to coxsackievirus A16 infection. Sample collection time and place also played a role in the enterovirus A71 and coxsackievirus A16 positive rates. The overall rates in January were significantly lower than those in April and August (p < 0.01); enterovirus A71 positive rates in Jinan city (capital city of Shandong province) were lower than those in Jining city and Zibo city (p < 0.05); and oxsackievirus A16 positive rates in Jining city were significantly higher than those in Jinan city and Zibo city (p < 0.01).

conclusionThere were significant differences among age groups, locations, and time points in the seroprevalence rates of enterovirus A71 and coxsackievirus A16 neutralizing antibodies in healthy people in Shandong province.

Indexed as

Enterovirus A, HumanAdolescentAdultAntibodies, NeutralizingAntibodies, ViralChildChild, PreschoolChinaCoxsackievirus InfectionsEnterovirus InfectionsFemaleHumansInfantInfant, NewbornMaleMiddle AgedAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID27611441
PMCPMC5017641
OpenAlexW2509663658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.